巴西的性状态的治疗:一篇综述
1Hospital Israelita Albert Einstein, São Paulo SP, Brazil.
Arquivos de neuro-psiquiatria
|February 11, 2025
概括
状态 (SE) 管理需要及时治疗,优先考虑静脉注射的类药物和抗发作药物 (ASM). 耐火性SE需要治疗性昏迷,由于有限的数据,超耐火性SE的治疗以临床经验为指导.
科学领域:
- 神经学 神经学
- 紧急医疗 紧急医疗
- 临床药理学 临床药理学
背景情况:
- 状态 (SE) 是一种严重的神经紧急情况.
- 及时干预至关重要,因为在SE治疗中",时间是大脑".
- 确定的时间框架存在于诊断和治疗性SE.
研究的目的:
- 概述目前对 status epilepticus 的理解和管理策略.
- 定义耐火和超耐火的SE.
- 提供关于SE治疗升级的指导.
主要方法:
- 审查目前对SE的定义和处理方案.
- 讨论一线 (二) 和二线 (IV ASM) 疗法.
- 探索耐火性和超耐火性SE的先进治疗方法,包括治疗性昏迷诱导.
主要成果:
- 初始的SE治疗包括迅速地注射IV二胺,然后注射IVASM (巴西的芬伊托因, levetiracetam).
- 耐火性SE是用IV麻醉药物来控制,以诱导治疗性昏迷.
- 超耐火性SE,尽管诱导昏迷,但仍然存在,基于证据的治疗选择有限.
结论:
- 迅速和适当地治疗SE对于更好的结果至关重要.
- 治疗算法涉及从二类药物到ASM的连续步骤,如果需要,治疗性昏迷.
- 超耐火性SE的管理在很大程度上依赖于临床专业知识和病例报告.
相关概念视频
Electroconvulsive Therapy
22
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
22
Seizures: Classification
299
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
299
Antiepileptic Drugs: GABAergic Pathway Potentiators
310
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
310
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
216
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
216
Arteries of the Lower Limbs
177
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
177
Antiepileptic Drugs: Glutamate Antagonists
271
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
271


